Goldman Sachs Maintains Buy on Teradyne, Raises Price Target to $465

Benzinga Newsdesk www.benzinga.com Positive 74.8%

Neg 0% Neu 0% Pos 74.8%

Goldman Sachs analyst James Schneider maintains Teradyne (NASDAQ:TER) with a Buy and raises the price target from $350 to $465.